Hyderabad (Telangana) [India], January 10 (ANI/PRNewswire): Sai Life Sciences, one of India's fastest-growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced that it has entered a 5-year strategic agreement with Schrodinger, whose physics-based computational platform is transforming the way therapeutics and materials are discovered, to set up the SaiSchrodinger Research Laboratories (SSRL) in Hyderabad, India. Being built inside Sai Life Sciences' R&D campus in genome valley, Hyderabad, SSRL will be a dedicated facility for integrated discovery work streams including medicinal & synthetic chemistry, in vitro biology, and process chemistry. It will access other Sai capabilities such as in vitro ADME and in vivo PK as needed. The relationship will support the advancement of programs that leverage Schrodinger's validated computational platform. Making the announcement, Krishna Kanumuri, CEO & Managing Director, of